Proof of Usefulness Report

OneOme

Analysis completed on 1/27/2026

+559
Proof of Usefulness Score
Industry Mainstay

OneOme is a legitimate, well-established pharmacogenomics company co-founded by Mayo Clinic (verified launch 2014) with estimated annual revenue between $4.5M and $12M. The project demonstrates high real-world utility and technical innovation in precision medicine. However, the submission itself contained inaccurate and lazy claims (e.g., 'most people have used my product', 'marketcap: null'), which heavily penalized the Evidence of Traction and Response Quality scores despite the verifiable external success.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+225
Audience Reach Impact+60
Technical Innovation+135
Evidence Of Traction+100
Market Timing Relevance+85
Functional Completeness+2.5
Subtotal+607.5
Usefulness Multiplierx0.92
Final Score+559

Project Details

Project URL
Description
We are a precision medicine leader, providing evidence-based pharmacogenomic solutions that facilitate more personalized prescriptions across the globe. Our RightMed Solution helps healthcare organizations, providers, and payers optimize patient outcomes and reduce costs by facilitating more personalized prescriptions. Paired with an in-house CLIA-certified, CAP-accredited lab, OneOme’s RightMed Test provides powerful genetic insights that doctors, pharmacists, and other healthcare providers can use to help inform medication decisions for their patients.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline